Research

In select primary care offices in the University of Vermont Health Network, patients may now undergo genetic testing that identifies differences in an individual’s DNA that make certain diseases such as cancer and heart disease more likely. But what are the goals of the service and how do patients benefit? Robert Wildin, M.D., associate professor of pathology and laboratory medicine and pediatrics and associate medical director of genomic medicine, dispels some myths about genomic medicine.
In select primary care offices in the University of Vermont Health Network, patients may now undergo genetic testing that identifies differences in an individual’s DNA that make certain diseases such as cancer and heart disease more likely. But what are the goals of the service and how do patients benefit? Read more…